Back
Citius Pharmaceuticals, Inc. 10K Form
Sell
42
CTXR
Citius Pharmaceuticals, Inc.
Last Price:
$1.23
Seasonality Move:
23.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTXR News And Ratings
See the #1 stock for the next 7 days that we like better than CTXR
CTXR Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-5.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.49 |
| Price / Book: | 0.35 |
Profitability
| EPS (TTM): | -5.09000 |
|---|---|
| Net Income (TTM): | $-42.1M |
| Gross Margin: | $-209.6K |
| Return on Equity: | -58.36% |
| Return on Assets: | -36.05% |
Citius Pharmaceuticals, Inc. Earnings Forecast
Key Citius Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 6 years.
Citius Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CTXR |
| CUSIP: | 17322U |
| Website: | citiuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 0.47 |
| Quick Ratio: | 0.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0.4 |
CTXR Technical Analysis vs Fundamental Analysis
Sell
42
Citius Pharmaceuticals, Inc. (CTXR)
is a Sell
Is Citius Pharmaceuticals, Inc. a Buy or a Sell?
-
Citius Pharmaceuticals, Inc. stock is rated a SellThe current Citius Pharmaceuticals, Inc. [CTXR] share price is $1.25. The Score for CTXR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.